Reinforcing its long-established reputation for quality and reliability as the steward for credible biomaterial and standards in the biological sciences, ATCC announces details of its new initiative, Incredible 2020.
ATCC announces the availability of its new PCR-based service to detect mycoplasma contamination in cell cultures.
ATCC hosting several networking events at the ASM Microbe 2018 conference to bring together the scientific community for discussions on advancements in molecular microbiology research and applications.
ATCC showcases its expanded portfolio of cancer research tools at the annual meeting of the American Association for Cancer Research (AACR).
ATCC awarded a 10-year contract through the U.S. Department of Defense’s (DoD) Joint Enterprise-Research, Development, Acquisition, and Production/Procurement (JE-RDAP), an omnibus Indefinite Delivery Indefinite Quantity (IDIQ) contract vehicle to attain future research, development, acquisition, procurement and fielding of CBRNE defense systems, equipment and materiel.
ATCC and BioAgilytix host the first “Trends in Cell-Based Assays” corporate forum to bring together subject matter experts from numerous pharmaceutical companies in the biotech community.